Steroids Pose Immense Risk of Increased Morbidity to IBD Patients
More than 6.8 million people suffer with inflammatory bowel disease (IBD), many of whom are at risk of increased morbidity due to an overreliance on steroids as a main pillar of treatment.[1] ...
Reshaping the Steroid Paradox
During 2023, the Steritas team had the opportunity to speak with a range of inspiring clinical research leaders who shared their expertise with us and our colleagues. Every conversation underscored ...
New Insights on the Impact of IgG4-related Disease
Although ongoing research continues to advance our understanding of IgG4-related disease (IgG4-RD), the epidemiology and downstream consequences of this relatively rare and complex autoimmune ...
In Conversation With… Paul Brunetta, MD
“Anywhere that steroids are being used in clinical studies, especially randomized controlled studies, there is a place for the GTI.” Paul Brunetta, MD is a physician and clinical researcher with 14 ...
Surge in Adoption of the Steritas eCOA Suite Continues
Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
